Nycomed GmbH
- Pharmaceutical Sales 2009
-
worldwide: 1.549 billion Euro
in Germany: 466 million Euro
- Product Range
- A differentiated portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. An extensive range of OTC products completes the portfolio.
- Key Research Areas
- A differentiated portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management.
- R&D Expenditure 2009
-
worldwide: 159 million Euro
- Employees in the Pharmaceuticals Division 2009
-
worldwide: 12,000
in Germany: 2,899
(All data based on corporate information, as of: 07/2011)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page